Combined First Month Body Weight Loss and Development of Tolerance as Predictors of 6-Month Efficacy of Mazindol in Mild and Moderate Obese Subjects
The weight loss response to anti-obesity drugs is highly variable and poorly understood, which does not allow us to know, in advance, in which subjects the drug will be effective and in which it will not. The objective of this study was to explore the body weight reduction in kilograms in the first...
Main Authors: | Juan Carlos Huerta-Cruz, Héctor Isaac Rocha-González, Ashuin Kammar-García, Samuel Canizales-Quinteros, Lina Marcela Barranco-Garduño, Juan Gerardo Reyes-García |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/11/3211 |
Similar Items
-
Changes in Body Weight in Severely Obese Patients Treated with the Anorexiant Mazindol
by: Yoshimitsu Tanaka, et al.
Published: (2024-03-01) -
Weight Loss at First Month and Development of Tolerance as Possible Predictors of 30 mg Phentermine Efficacy at 6 Months
by: Héctor Isaac Rocha-González, et al.
Published: (2021-12-01) -
Key Factors in Effective Patient-Tailored Dosing of Fluoroquinolones in Urological Infections: Interindividual Pharmacokinetic and Pharmacodynamic Variability
by: Oskar Estradé, et al.
Published: (2022-05-01) -
Evaluation of the usefulness of saliva for DNA methylation analysis in cohort studies
by: Yui Murata, et al.
Published: (2019-12-01) -
Reference intervals of biochemical parameters in Chilean adults
by: Letelier Pablo, et al.
Published: (2024-01-01)